Health Care Delivery

Latest News


Video Series


Latest Videos


Shorts

How Rhenium Nanoliposomes Target Leptomeningeal Metastases: Andrew Brenner, MD
0:41
How Rhenium Nanoliposomes Target Leptomeningeal Metastases: Andrew Brenner, MD
5 days ago
by
Sabrina McCrear(+1 more)
Understanding LM Therapy Across Breast Cancer Subtypes: Andrew Brenner, MD
1:11
Understanding LM Therapy Across Breast Cancer Subtypes: Andrew Brenner, MD
6 days ago
by
Sabrina McCrear(+1 more)
Antonio Urbina, MD
0:58
Changes to USAID Affected Worldwide HIV Response: Antonio Urbina, MD
13 days ago
by
Julia Bonavitacola(+1 more)
Brian Reid, MS
1:52
DTC Models Offer Promise for Some, but Remain Limited in Scope: Brian Reid, MS
18 days ago
by
Brooke McCormick(+1 more)
Jennifer Graff, PharmD
0:53
Treatments for Symptom-Driven Conditions Are the Best Fit for DTC Models: Jennifer Graff, PharmD
19 days ago
by
Brooke McCormick(+1 more)
Vtama Shows Strong Efficacy and Safety Even in Patients With Comorbidities: Druhan Howell, MD
0:26
Vtama Shows Strong Efficacy and Safety Even in Patients With Comorbidities: Druhan Howell, MD
a month ago
by
Sabrina McCrear(+1 more)
Dr Joey Mattingly
2:25
Holistic Care Coordination Should Take Priority Over Lower Drug Prices: Joey Mattingly, PharmD, PhD, MBA
a month ago
by
Brooke McCormick(+1 more)
Dr Joey Mattingly
2:30
TrumpRx Rollout Marked by Unclear Impact, Emerging Safety Concerns: Joey Mattingly, PharmD, MBA, PhD
a month ago
by
Brooke McCormick(+1 more)
Dr Joey Mattingly
0:52
DTC Pharmacy Models Shake Up Traditional Drug Distribution: Joey Mattingly, PharmD, MBA, PhD
a month ago
by
Brooke McCormick(+1 more)
The Trade-Off: Side Effects vs Longer Life on New Cancer Treatments: Melanie Sheen, MD
0:34
The Trade-Off: Side Effects vs Longer Life on New Cancer Treatments: Melanie Sheen, MD
a month ago
by
Sabrina McCrear(+1 more)

Podcasts


CME Content


More News

AJMC commentary

The foundation of medically integrated pharmacy includes 7 critical pillars. This commentary focuses on the benefits of 3 of those pillars: abandonment, adherence, and access/affordability.

AJMC original research clinical

Within the same physician groups, 2-sided risk in Medicare Advantage (MA) was associated with higher quality and lower utilization for dually eligible beneficiaries compared with fee-for-service MA and traditional Medicare.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo